Outcome of Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation as a Treatment Option in Patients With Severe Aplastic Anemia Between 40 and 50 Years.
Hematol Oncol Stem Cell Ther
; 15(1): 52-58, 2022 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-32652051
Full text:
1
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Graft vs Host Disease
/
Anemia, Aplastic
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Hematol Oncol Stem Cell Ther
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
Iran